Author

L. Lanikova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

D. Hrckulak· 1 shared E. Sloncova· 1 shared H. Strnad· 1 shared J. Svec· 1 shared L. Janeckova· 1 shared M. Vojtechova· 1 shared N. Dibus· 1 shared V. Korinek· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. Hrckulak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumor suppressor Hypermethylated in Cancer 1 represses expression of cell cycle regulator E2F7 in human primary cells

L. Lanikova, J. Svec, L. Janeckova, V. Pospichalova, N. Dibus, M. Vojtechova, D. Hrckulak, E. Sloncova, H. Strnad, V. Korinek

This study shows that HIC1 represses E2F7, leading to altered cell cycle progression and DNA repair in CRC, with E2F7 levels linked to patient prognosis.

bioRxiv · Jul 25, 2022 · PreprintCancer Biology